Drug profile · INN
carphenazine maleate
PROKETAZINE
carphenazine maleate (PROKETAZINE) is a dopamine d2 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — carphenazine maleate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
carphenazine maleate (PROKETAZINE) is a dopamine d2 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Dopamine D2 receptor antagonist
Primary target: D(2) dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is carphenazine maleate?
carphenazine maleate (PROKETAZINE) is a dopamine d2 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for carphenazine maleate?
PROKETAZINE is a marketed brand name for carphenazine maleate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of carphenazine maleate?
carphenazine maleate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.